Display options
Cite
Baessler A, Lamounier-Zepter V, Fenk S, et al. Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects. Nutr Diabetes. 2014;4:e106doi: 10.1038/nutd.2014.3.
Baessler, A., Lamounier-Zepter, V., Fenk, S., Strack, C., Lahmann, C., Loew, T., Schmitz, G., Blüher, M., Bornstein, S. R., & Fischer, M. (2014). Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects. Nutrition & diabetes, 4e106. https://doi.org/10.1038/nutd.2014.3
Baessler, A, et al. "Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects." Nutrition & diabetes vol. 4 (2014): e106. doi: https://doi.org/10.1038/nutd.2014.3
Baessler A, Lamounier-Zepter V, Fenk S, Strack C, Lahmann C, Loew T, Schmitz G, Blüher M, Bornstein SR, Fischer M. Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects. Nutr Diabetes. 2014 Feb 10;4:e106. doi: 10.1038/nutd.2014.3. PMID: 24513579; PMCID: PMC3940827.
Copy Download .nbib Format: NLM
Share it on

Nutr Diabetes. 2014 Feb 10;4:e106. doi: 10.1038/nutd.2014.3.

Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects.

Nutrition & diabetes

A Baessler, V Lamounier-Zepter, S Fenk, C Strack, C Lahmann, T Loew, G Schmitz, M Blüher, S R Bornstein, M Fischer

Affiliations

  1. Clinic for Internal Medicine II, University of Regensburg, Regensburg, Germany.
  2. Medical Clinic III, Dresden University of Technology, Germany.
  3. Clinic for Psychosomatic Medicine, Technical University of Munich, Munich, Germany.
  4. Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg, Germany.
  5. Department of Medicine, University of Leipzig, Leipzig, Germany.

PMID: 24513579 PMCID: PMC3940827 DOI: 10.1038/nutd.2014.3

Abstract

OBJECTIVES: This study aimed to examine the association of adipocyte fatty acid-binding protein (FABP4) levels with left ventricular diastolic dysfunction (LVDD) in obese subjects with varying degrees of the metabolic syndrome (MetS).

METHODS: Fifty morbidly obese subjects with LVDD were selected at random and matched by age (±5 years) and sex with 50 morbidly obese with normal left ventricular (LV) function. In addition, 24 healthy lean subjects were included as controls.

RESULTS: Median FABP4 levels (interquartile range) in obese subjects with LVDD were significantly higher (42 ng ml(-1) (32-53)) than in obese with normal LV function (24 ng ml(-1) (36-43), P=0.036), and in normal weight controls (13 ng ml(-1) (10-20), P<0.0001). Increasing FABP4 tertiles were significantly associated with parameters of LVDD, the number of LVDD components, physical performance and epicardial fat thickness. In multivariate regression analysis adjusting for age, sex and adiposity, FABP4 levels remained significantly associated with parameters of diastolic function. The association of FABP4 levels with LVDD was mainly observed in subjects with metabolic complications, but not in metabolically healthy obese.

CONCLUSIONS: FABP4 levels are significantly associated with LVDD in obese subjects, when the MetS is present. Thus, FABP4 may be a link between obesity and cardiometabolic disorders.

References

  1. Circulation. 2012 Feb 14;125(6):782-8 - PubMed
  2. Science. 1996 Nov 22;274(5291):1377-9 - PubMed
  3. J Atheroscler Thromb. 2012;19(6):539-51 - PubMed
  4. PLoS One. 2012;7(11):e48605 - PubMed
  5. Circulation. 2007 Mar 27;115(12):1537-43 - PubMed
  6. Naunyn Schmiedebergs Arch Pharmacol. 2011 Sep;384(3):255-63 - PubMed
  7. Eur J Clin Invest. 2006 Sep;36(9):621-5 - PubMed
  8. Proc Natl Acad Sci U S A. 2006 May 2;103(18):6970-5 - PubMed
  9. Curr Opin Lipidol. 2005 Oct;16(5):543-8 - PubMed
  10. Metabolism. 2009 Jul;58(7):1002-7 - PubMed
  11. Eur J Heart Fail. 2013 Apr;15(4):394-9 - PubMed
  12. Clin Sci (Lond). 2013 Jan;124(2):115-22 - PubMed
  13. Nat Rev Drug Discov. 2008 Jun;7(6):489-503 - PubMed
  14. Endocrinology. 2000 Sep;141(9):3388-96 - PubMed
  15. Eur J Heart Fail. 2012 Nov;14(11):1240-8 - PubMed
  16. Heart Fail Rev. 2002 Jan;7(1):17-27 - PubMed
  17. Eur J Endocrinol. 2011 Apr;164(4):539-47 - PubMed
  18. PLoS One. 2011 Apr 28;6(4):e19115 - PubMed
  19. Circ Res. 2009 Aug 14;105(4):326-34 - PubMed
  20. Cardiovasc Diabetol. 2013 May 04;12:72 - PubMed
  21. N Engl J Med. 2004 May 6;350(19):1953-9 - PubMed
  22. Circulation. 2009 May 26;119(20):2679-85 - PubMed
  23. Diabetologia. 2013 Jan;56(1):10-21 - PubMed
  24. Circulation. 2004 Jan 27;109(3):433-8 - PubMed
  25. Eur J Echocardiogr. 2009 Mar;10(2):165-93 - PubMed
  26. Heart. 2013 Jul;99(13):944-8 - PubMed
  27. J Lipid Res. 2008 Aug;49(8):1746-51 - PubMed
  28. J Am Coll Cardiol. 2009 Mar 17;53(11):905-18 - PubMed
  29. Clin Chem. 2006 Mar;52(3):405-13 - PubMed
  30. Eur Heart J. 2007 Oct;28(20):2539-50 - PubMed
  31. Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S17-22 - PubMed
  32. N Engl J Med. 2006 Jul 20;355(3):251-9 - PubMed
  33. Biometrics. 1989 Mar;45(1):255-68 - PubMed

Publication Types